Volume 94 Issue 8 | p. 7 | News of The Week
Issue Date: February 22, 2016 | Web Date: February 18, 2016

Pliant Launches To Tackle Fibrotic Diseases

Start-ups: Research from four UCSF labs provide foundation for well-financed biotech firm
Department: Business
Keywords: fibrosis, start-up

Another biotech firm is debuting with a hefty first round of financing. Rooted in work emerging from four labs at the University of California, San Francisco, Pliant Therapeutics is launching with $45 million in Series A funding from the venture capital firm Third Rock Ventures to develop treatments for fibrotic disorders.

Pliant is the result of several years of work by life sciences-focused Third Rock, which wanted to tap into a surge in research related . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society